YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  

Sanofi Buys More Regeneron Biotech Stocks

February 12, 2013 | Sanofi is buying more shares of Regeneron Pharmaceuticals, its current partner on cholesterol and rheumatoid arthritis. Sanofi currently controls 16.7% of the company but has the right to control up to 30%. Both company's stocks rose on the announcement. Reuters
Click here to login and leave a comment.  


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.